Article Text

Download PDFPDF
Dissection of familial correlations in hepatitis C virus (HCV) seroprevalence suggests intrafamilial viral transmission and genetic predisposition to infection
  1. S Plancoulaine1,2,
  2. M K Mohamed3,
  3. N Arafa3,
  4. I Bakr3,
  5. C Rekacewicz4,
  6. D-A Trégouët5,
  7. D Obach1,2,4,
  8. M El Daly6,7,
  9. V Thiers8,
  10. C Féray9,
  11. M Abdel-Hamid7,10,
  12. L Abel1,2,
  13. A Fontanet4
  1. 1
    Laboratoire de Génétique Humaine des Maladies Infectieuses, Institut National de la Santé et de la Recherche Médicale, Paris, France
  2. 2
    Université Paris Descartes, Faculté de Médecine Necker, Paris, France
  3. 3
    Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt
  4. 4
    Institut Pasteur, Unité d’Epidémiologie des Maladies Emergentes, Paris, France
  5. 5
    INSERM, UMR S 525, Paris, France; UPMC Paris 6, UMR S 525, Paris, France
  6. 6
    National Liver Institute, Menophya, Egypt
  7. 7
    Viral Hepatitis Research Laboratory, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt
  8. 8
    Institut Pasteur, Laboratoire associé au CNR pour les hépatites virales B, C et Delta, Hôpital Paul Brousse, Villejuif, France
  9. 9
    INSERM, Centre Investigation Clinique 04, Hôtel-Dieu, Nantes, France
  10. 10
    Department of Microbiology, Minia Faculty of Medicine, Minia, Egypt
  1. Dr S Plancoulaine, INSERM U550, Laboratoire de Génétique Humaine des Maladies Infectieuses, Faculté de Médecine Necker, 156 rue de Vaugirard, 75015 Paris; plancoulaine{at}


Objective: Unsafe injections and transfusions used during treatments are considered to be responsible for many cases of transmission of hepatitis C virus (HCV) in developing countries, but cannot account for a substantial proportion of present infections. The aim of the present work was to investigate familial clustering of HCV infection in a population living in a highly endemic area.

Design, setting and participants: A large seroepidemiological survey was conducted on 3994 subjects (age range, 2–88 years) from 475 familial clusters in an Egyptian rural area. Epidemiological methods appropriate for the analysis of correlated data were used to estimate risk factors and familial dependences for HCV infection. A phylogenetic analysis was conducted to investigate HCV strain similarities within and among families.

Main outcome measures: HCV familial correlations adjusted for known risk factors, similarities between viral strains.

Results: Overall HCV seroprevalence was 12.3%, increasing with age. After adjustment for relevant risk factors, highly significant intrafamilial resemblances in HCV seroprevalence were obtained between father–offspring (odds ratio (OR) = 3.4 (95% confidence interval (CI), 1.8 to 6.2)), mother–offspring (OR = 3.8 (95% CI, 2.5 to 5.8)), and sibling–sibling (OR = 9.3 (95% CI, 4.9 to 17.6)), while a weaker dependence between spouses (OR = 2.2 (95% CI, 1.3 to 3.7)) was observed. Phylogenetic analysis showed greater HCV strain similarity between family members than between unrelated subjects, indicating that correlations can be explained, in part, by familial sources of virus transmission. In addition, refined dissection of correlations between first-degree relatives supported the role of host genes predisposing to HCV infection.

Conclusions: Current HCV infection in endemic countries has a strong familial component explained, at least partly, by specific modes of intrafamilial viral transmission and by genetic predisposition to infection.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Supplementary information concerning the epidemiological factors investigated is published online only at

  • LA and AF are joint senior authors.

  • Funding: This work was supported by grants from Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) (12107); Institut Pasteur; Institut National de la Santé et de la Recherche Médicale (INSERM); and Fondation Banque Nationale de Paris–Paribas.

  • Competing interests: None.

  • Ethics approval: The Institutional Review Board of the Egyptian Ministry of Health and Population, and an ad hoc ethics committee created to examine the protocols of studies on viral hepatitis in Egypt, approved the entire protocol on 3 July 2001.